Tuesday, 2 April 2024, 7:00pm - 8:30pm AEDT In this webinar A/Prof Michael Woodward, Prof Grant Waterer and Dr Victoria Hayes, explore prevalence, seasonal patterns, and demographic impacts of respiratory syncytial virus (RSV) in Australia. It will also outline preventative measures in older age groups, including safety and efficacy features of the new RSV vaccine for adults.
This 1.5-hour educational module explores how to identify affected patients with a family history of cancer and provides an overview of how Familial Cancer Centres can assist these patients through genetic testing and risk management.
In this clinical audit you will conduct a review of patients with pancreatic exocrine insufficiency (PEI) who are currently receiving PERT (pancreatic enzyme replacement therapy), in order to assess their quality of life and treatment effectiveness, and optimise their therapy.
In this two-part clinical audit, you will review your past management of patients with type 2 diabetes and overweight or obesity, then utilise your learnings to guide effective glycaemic and weight management of further patients.
Dementia care, post-diagnosis, spans a myriad of domains including medical, psychological, social, and functional. Embracing a multi-disciplinary approach is paramount for delivering holistic care. This on-demand webinar delves into collaborative multi-disciplinary strategies that can ensure a comprehensive assessment and tailored management plan, to meet the distinct goals and needs of people with dementia and their caregivers.
Review your management of patients with HFrEF (heart failure with reduced ejection fraction) in this clinical audit, and update their treatment to be in line with latest recommendations including the "four pillars" approach.
On-demand webinar - The opioid dependence treatment landscape is changing: What every GP needs to know
In this on-demand webinar we explore the new era in opioid dependence treatment and unpack the implications of these transformative changes, highlighting how they democratise access to treatments, including long-acting injectable buprenorphine (LAIB). While LAIBs play a critical role, they are part of a broader treatment landscape.
Mild cognitive impairment (MCI) is an increasingly prevalent condition in Australia, and GPs can play a key role in its identification and management through early diagnosis and action. This module explores how to identify risk factors and make a diagnosis of MCI, and outlines the effective development of treatment plans for MCI in primary care.